Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Raltegravir may cause hair loss in some patients.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

34% of patients on hepatitis C treatment had reversible skin issues.

Indinavir and ritonavir therapy can cause reversible hair loss.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Apremilast showed mixed results for treating severe alopecia areata.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The medication lopinavir-ritonavir may cause severe hair loss.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Apremilast improved symptoms in patients with severe skin conditions.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Apremilast did not work for treating severe alopecia areata.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Alopecia universalis can be an early sign of HIV.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Remembering to take PrEP is the main challenge, and urine monitoring is a preferred adherence method.